Jane Street’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.78M Buy
127,122
+10,646
+9% +$149K ﹤0.01% 2241
2025
Q1
$1.82M Buy
116,476
+11,035
+10% +$173K ﹤0.01% 2356
2024
Q4
$1.47M Sell
105,441
-5,631
-5% -$78.4K ﹤0.01% 2484
2024
Q3
$1.03M Sell
111,072
-39,033
-26% -$363K ﹤0.01% 3351
2024
Q2
$1.4M Sell
150,105
-63,431
-30% -$590K ﹤0.01% 3206
2024
Q1
$2.12M Buy
213,536
+52,935
+33% +$525K ﹤0.01% 2254
2023
Q4
$519K Buy
160,601
+37,576
+31% +$121K ﹤0.01% 4063
2023
Q3
$653K Sell
123,025
-29,802
-20% -$158K ﹤0.01% 3340
2023
Q2
$1.46M Buy
152,827
+126,572
+482% +$1.21M ﹤0.01% 2716
2023
Q1
$289K Buy
+26,255
New +$289K ﹤0.01% 4294
2022
Q4
Sell
-19,081
Closed -$365K 5482
2022
Q3
$365K Buy
+19,081
New +$365K ﹤0.01% 3973
2022
Q2
Sell
-14,398
Closed -$277K 5501
2022
Q1
$277K Buy
+14,398
New +$277K ﹤0.01% 4386
2020
Q4
Sell
-10,959
Closed -$321K 3843
2020
Q3
$321K Buy
+10,959
New +$321K ﹤0.01% 2805